139 related articles for article (PubMed ID: 15808156)
21. Does conventional laser photocoagulation still have a place in the treatment of diabetic macular edema?
Kayhan B; Burumcek E
Rom J Ophthalmol; 2021; 65(2):130-135. PubMed ID: 34179577
[No Abstract] [Full Text] [Related]
22. Enhanced depth imaging optical coherence tomography in type 2 diabetes.
Querques G; Lattanzio R; Querques L; Del Turco C; Forte R; Pierro L; Souied EH; Bandello F
Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6017-24. PubMed ID: 22879414
[TBL] [Abstract][Full Text] [Related]
23. Posterior sub-Tenon's capsule triamcinolone injection combined with focal laser photocoagulation for diabetic macular edema.
Tunc M; Onder HI; Kaya M
Ophthalmology; 2005 Jun; 112(6):1086-91. PubMed ID: 15885789
[TBL] [Abstract][Full Text] [Related]
24. Progression of diabetic macular edema: correlation with blood retinal barrier permeability, retinal thickness, and retinal vessel diameter.
Sander B; Thornit DN; Colmorn L; Strøm C; Girach A; Hubbard LD; Lund-Andersen H; Larsen M
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):3983-7. PubMed ID: 17724176
[TBL] [Abstract][Full Text] [Related]
25. A Revised Approach for the Detection of Sight-Threatening Diabetic Macular Edema.
Litvin TV; Bresnick GH; Cuadros JA; Selvin S; Kanai K; Ozawa GY
JAMA Ophthalmol; 2017 Jan; 135(1):62-68. PubMed ID: 27930756
[TBL] [Abstract][Full Text] [Related]
26. High prevalence of sleep disordered breathing in patients with diabetic macular edema.
Mason RH; West SD; Kiire CA; Groves DC; Lipinski HJ; Jaycock A; Chong VN; Stradling JR
Retina; 2012 Oct; 32(9):1791-8. PubMed ID: 22714043
[TBL] [Abstract][Full Text] [Related]
27. Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema.
Mirshahi A; Shenazandi H; Lashay A; Faghihi H; Alimahmoudi A; Dianat S
Retina; 2010 Feb; 30(2):254-9. PubMed ID: 20057344
[TBL] [Abstract][Full Text] [Related]
28. The effect of posterior subtenon methylprednisolone acetate in the refractory diabetic macular edema: a prospective nonrandomized interventional case series.
Javadzadeh A
BMC Ophthalmol; 2006 Apr; 6():15. PubMed ID: 16595011
[TBL] [Abstract][Full Text] [Related]
29. A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: report 3.
Rajendram R; Fraser-Bell S; Kaines A; Michaelides M; Hamilton RD; Esposti SD; Peto T; Egan C; Bunce C; Leslie RD; Hykin PG
Arch Ophthalmol; 2012 Aug; 130(8):972-9. PubMed ID: 22491395
[TBL] [Abstract][Full Text] [Related]
30. Retinal thickness measurement and evaluation of natural history of the diabetic macular edema through optical coherence tomography.
Hannouche RZ; Avila MP
Arq Bras Oftalmol; 2009; 72(4):433-8. PubMed ID: 19820779
[TBL] [Abstract][Full Text] [Related]
31. Effect of grid decentration on macular thickness measurements in normal subjects and patients with diabetic macular edema.
Falavarjani KG; Khadamy J; Safi H; Karimi N; Amirkourjani F
Eur J Ophthalmol; 2015; 25(3):218-21. PubMed ID: 25449639
[TBL] [Abstract][Full Text] [Related]
32. Association Between Vessel Density and Visual Acuity in Patients With Diabetic Retinopathy and Poorly Controlled Type 1 Diabetes.
Dupas B; Minvielle W; Bonnin S; Couturier A; Erginay A; Massin P; Gaudric A; Tadayoni R
JAMA Ophthalmol; 2018 Jul; 136(7):721-728. PubMed ID: 29800967
[TBL] [Abstract][Full Text] [Related]
33. Ranibizumab for diabetic macular edema difficult to treat with focal/grid laser.
Kotsolis AI; Tsianta E; Niskopoulou M; Masaoutis P; Baltatzis S; Ladas ID
Graefes Arch Clin Exp Ophthalmol; 2010 Nov; 248(11):1553-7. PubMed ID: 20585799
[TBL] [Abstract][Full Text] [Related]
34. Optical coherence tomographic assessment of macular thickness and morphological patterns in diabetic macular edema: prognosis after modified grid photocoagulation.
Shrestha A; Maharjan N; Shrestha A; Thapa R; Poudyal G
Nepal J Ophthalmol; 2012; 4(1):128-33. PubMed ID: 22344010
[TBL] [Abstract][Full Text] [Related]
35. Effect of photocoagulation on center point thickness in diabetic macular edema.
Lima-Gómez V; Razo Blanco-Hernández DM; Asbun-Bojalil J
Cir Cir; 2011; 79(5):395-401. PubMed ID: 22385758
[TBL] [Abstract][Full Text] [Related]
36. Ethnicity, race, and clinically significant macular edema in the Veterans Affairs Diabetes Trial (VADT).
Emanuele N; Moritz T; Klein R; Davis MD; Glander K; Khanna A; Thottapurathu L; Bahn G; Duckworth W; Abraira C;
Diabetes Res Clin Pract; 2009 Nov; 86(2):104-10. PubMed ID: 19720420
[TBL] [Abstract][Full Text] [Related]
37. Microperimetry and fundus autofluorescence in diabetic macular edema: subthreshold micropulse diode laser versus modified early treatment diabetic retinopathy study laser photocoagulation.
Vujosevic S; Bottega E; Casciano M; Pilotto E; Convento E; Midena E
Retina; 2010 Jun; 30(6):908-16. PubMed ID: 20168272
[TBL] [Abstract][Full Text] [Related]
38. Repeatability of Retinal Macular Thickness Measurements in Healthy Subjects and Diabetic Patients with Clinically Significant Macular Edema: Evaluation of the Follow-Up System of Spectralis Optical Coherence Tomography.
Fiore T; Lupidi M; Androudi S; Giansanti F; Fruttini D; Cagini C
Ophthalmologica; 2015; 233(3-4):186-91. PubMed ID: 25871801
[TBL] [Abstract][Full Text] [Related]
39. Fundus microperimetry patterns of fixation in type 2 diabetic patients with diffuse macular edema.
Carpineto P; Ciancaglini M; Di Antonio L; Gavalas C; Mastropasqua L
Retina; 2007 Jan; 27(1):21-9. PubMed ID: 17218911
[TBL] [Abstract][Full Text] [Related]
40. Diabetic macular edema: correlation between microperimetry and optical coherence tomography findings.
Vujosevic S; Midena E; Pilotto E; Radin PP; Chiesa L; Cavarzeran F
Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):3044-51. PubMed ID: 16799051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
